E, CIB, COLB, DCI and WPC stand out with strong shareholder yield, blending income, buybacks and debt reduction for portfolio defense.

GUANGZHOU, China , Aug. 18, 2025 /PRNewswire/ -- Leading investment management firms are backing Pony.ai. Recent corporate filings reveal ARK Invest, Cathie Wood's firm, invested roughly US$12.9 million in the Chinese autonomous driving company in August.

GoodRx announces a collaboration with Novo Nordisk to make Ozempic cheaper for self-paying patients.

Amazon's aggressive expansion into same-day fresh grocery delivery aims to capture a larger share of the $940B US grocery market and deepen Prime integration. Leveraging vast logistics, data analytics, and a $4B infrastructure investment, Amazon is positioned to compete directly with Walmart and Instacart for market leadership. DCF and SOTP analysis support a $265 price target, with bullish growth assumptions tied to grocery expansion and Amazon's robust financial performance.

Pharmaceutical powerhouse Novo Nordisk (NYSE:NVO) is charging 3.1% higher to trade at $54.10, after its weight-loss drug Wegovy landed Food and Drug Administration (FDA) approval to be used in the treatment of liver disease in the U.S. Today's pop comes just weeks after the company slashed its 2025 profit outlook and appointed a new CEO, resulting in a 21.8% bear gap on July 29, its worst drop on record.

ABT Nutrition unit posts steady gains as adult-focused brands like Ensure and Glucerna drive global demand and market share growth.

If you are looking for stocks that are well positioned to maintain their recent uptrend, NCS Multistage (NCSM) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Array Technologies (ARRY) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

If you are looking for stocks that are well positioned to maintain their recent uptrend, Kiniksa Pharmaceuticals International, plc (KNSA) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

If you are looking for stocks that are well positioned to maintain their recent uptrend, Adtalem (ATGE) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, fuboTV (FUBO) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Kimball Electronics (KE) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Potbelly (PBPB) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

GrowGeneration (GRWG) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Yext's CEO Michael Walrath has proposed taking the search optimization company private in a deal valued at about $1.1 billion, it said on Monday, sending shares up 9% in early trading.

Companies can receive a big boost on impressive results or promising news, and then it is a matter of maintaining momentum to ensure those gains aren't given back shortly after.

Horace Mann Educators delivers strong financial results, with Q2 2025 earnings up nearly 80% and core EPS guidance raised for the year. The company maintains a disciplined capital return policy, boasting a 3.14% dividend yield and consistent share buybacks. Despite an educator-focused customer base, recent acquisitions and low market penetration offer significant growth potential.

Evercore ISI added Target (TGT) to its "tactical outperform" list after the retail giant's stock has been beaten down over the last year. As Jenny Horne notes, the firm also moved Lowe's (LOW) to its "tactical underperform" list.

SAN DIEGO , Aug. 18, 2025 /PRNewswire/ -- The Shareholders Foundation, Inc. announces that a deadline is coming up in the lawsuit for certain investors in shares of Alto Neuroscience, Inc. (NYSE: ANRO). Investors who purchased in excess of $100,000 in shares of Alto Neuroscience, Inc. (NYSE: ANRO) between February 2, 2024 and October 22, 2024, have certain options and there are short and strict deadlines running.